Clinical Trials Logo
  1. Home
  2. Left Ventricular Thrombus
  3. NCT05077683

Direct Oral Anticoagulants for Prevention of lEft ventRIcular Thrombus After Anterior Acute Myocardial InFarction - APERITIF — APERITIF  

Myocardial Infarction, Acute Clinical Trial

Official title:
Direct Oral Anticoagulants for Prevention of lEft ventRIcular Thrombus After Anterior Acute Myocardial InFarction

Clinical Trial Summary

APERITIF is a prospective randomized open-label, blinded end-point (PROBE) trial, nested in the ongoing the "FRENCHIE" registry, a French multicenter prospective observational study granted by "ANR-RHU Grand Emprunt", in which all consecutive patients admitted within 48 hours after symptom onset in a cardiac Intensive Care Unit (ICU) for an acute myocardial infarction (AMI) are included (NCT04050956). Among them, eligible Patients for "APERITIF" will be randomized into two groups: Dual Anti-Platelet Therapy (DAPT) alone or DAPT plus rivaroxaban 2.5mg twice daily for 4 weeks, prescribed as soon as possible after admission and completion of the initial percutaneous coronary intervention/angiography procedure.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05077683
Study type Interventional
Source Assistance Publique - Hôpitaux de Paris
Contact
Status Active, not recruiting
Phase Phase 3
Start date October 18, 2021
Completion date December 2024
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05759078 - Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Deficient Patients With Recent Myocardial infarCTion Phase 4
Completed NCT06408636 - Prognostic Role of LA Strain in Acute Myocardial Infarction
Recruiting NCT06038994 - Prognostic Value of Surem TRAF3IP2 Level in Patients With Acute Myocardial Infarction
Recruiting NCT04968808 - Timing of FFR-guided PCI for Non-IRA in NSTEMI and MVD (OPTION-NSTEMI) N/A
Completed NCT03338504 - Determining the Mechanism of Myocardial Injury and Role of Coronary Disease in Type 2 Myocardial Infarction
Recruiting NCT03317691 - The ALERT-Pilot Study N/A
Recruiting NCT03957005 - Cardiovascular Risk Assessment Model in Patients With MI
Enrolling by invitation NCT05955950 - Gratitude Intervention in Promoting Self-care in Patients With Myocardial Infarction N/A
Active, not recruiting NCT06141252 - Benefit of Hypothermia in OHCA Complicating AMI N/A
Not yet recruiting NCT04560023 - Effectiveness of Multimedia Exposure in Patients Transferred to Hospital Suffering From Acute Myocardial Infarction N/A
Terminated NCT03809689 - Study of Cardiac Lesions Angiogenesis by 68Ga-NODAGA-RGD Cardiac PET N/A
Recruiting NCT06430892 - RAPID-POP a Randomized Controlled Trial N/A
Completed NCT05118009 - Artificial Intelligence Based Rapid Identification of ST-elevation Myocardial Infarction Using Electrocardiogram (ARISE) N/A
Active, not recruiting NCT04753749 - Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy N/A
Completed NCT04769219 - Secondary Prevention Education After Acute Myocardial Infarction N/A
Active, not recruiting NCT05350969 - Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction Phase 2
Recruiting NCT05999110 - Algarve Active Ageing - Cardiac and Osteoarthritis Rehabilitation (A3-COR) N/A
Completed NCT04167904 - Biomarkers in Patients Hospitalized With Suspected Acute Myocardial Infarction
Not yet recruiting NCT04989777 - IABP In AMI Patients With SCAI-B Study N/A
Recruiting NCT05043610 - MSCs for Prevention of MI-induced HF Phase 3